GO
View AllPharmaBiotechMedical
Devices
Health
Care
Animal
Health
8 February 2019
The General Court’s judgment in Krka – some welcome clarity over licensing in the context of patent settlements

We reported on this blog about the General Court (GC)’s judgment in Servier on the day on...

10 January 2019
CRISPR gene editing technology and its many applications

The revolutionary CRISPR-Cas9 gene editing technology is regularly in the headlines, much of the time...

12 December 2018
Partial annulment of Servier decision by the General Court – some good news for pharma innovators at last

The General Court has today handed down its judgment in the long-running Servier patent settlement case. 

5 December 2018
What is the best response to higher prices in the pharma sector?

The European Commission published a Draft Withdrawal Agreement (the Agreement) on 19 March 2018. The Agreement...

4 October 2018
Request to re-open Glaxo ‘dual pricing’ case rejected by General Court: The end of the road for challenges to dual pricing?

Entering into agreements that erect barriers to parallel exports between EU markets is generally a...

14 August 2018
Concordia and the CMA – a drama in (at least) three parts

Last week, Concordia International released a management report in which it announced the names of six drugs...

30 July 2018
The EMA’s clinical data publication policy: 1 year on

On 16 July 2018, the EMA published a report on the first year (Oct 2016...

4 July 2018
CJEU follows Advocate General’s Opinion to confirm the scope of the Specific Mechanism

On 21 June 2018 the CJEU gave its judgment in a preliminary reference from the...

20 June 2018
The CAT sets a clear framework for excessive and unfair prices in its Pfizer/Flynn judgment

The Competition Appeal Tribunal (CAT) recently gave its judgment in Pfizer and Flynn’s appeal of...

14 May 2018
Depression Delayed: CMA’s paroxetine pay-for-delay case heads to Luxembourg

On 8 March 2018, the Competition Appeal Tribunal (CAT) gave an initial judgment in appeals brought by...

5 April 2018
We have our transition period for goods but what about the regulations? How the life sciences industry may be affected by Brexit

The European Commission published a Draft Withdrawal Agreement (the Agreement) on 19 March 2018. The Agreement...

16 February 2018
Different types of value transfer in ‘reverse payment’ settlement agreements

In recent years, competition authorities and courts in the EU and the US have paid...

123456>>>